TIS Inc., part of TIS INTEC Group (HQ: Shinjuku-ku, Tokyo; President Toru KUWANO; hereinafter TIS), and the French company IDEMIA, the global leader in Augmented Identity (HQ: France, CEO Didier LAMOUCHE; Japanese corporation: IDEMIA Japan KK; HQ: Chiyoda-ku, Tokyo; Representative Director Nobuyoshi NEZU; hereinafter IDEMIA) today announced the launch of joint research and development of biometric digital identity solutions for financial institutions.
COLOMBES, France-Saturday, June 2nd 2018 [ AETOS Wire ]
(BUSINESS WIRE)-- Going forward, the two companies aim to conduct verification testing in Japan throughout 2018 targeted at financial institutions such as banks and credit card companies, amongst others, through joint research and development of highly secure and reliable biometric digital identity solutions based on IDEMIA’s digital identity and payment platform.
Biometric digital identity solutions for financial institutions are solutions that suppo
...
Read more »
|
LACHEN, Switzerland-Tuesday, May 29th 2018 [ AETOS Wire ]
(BUSINESS WIRE) -- Octapharma announced today that pre-clinical data for SubQ-8 were presented during a symposium at the recent World Federation of Hemophilia (WFH) 2018 World Congress in Glasgow, UK. SubQ-8, currently under development, is a recombinant FVIII from a human cell line for subcutaneous administration. SubQ-8 is based on Octapharma’s human cell line-derived rFVIII product simoctocog alpha combined with a fragment of the von Willebrand Factor (VWF) protein, and harnesses the protective power of VWF in an innovative approach to facilitate transportation of FVIII into the circulation.
Regular intravenous administration of FVIII poses a considerable burden to people with haemophilia A and their families. Alternative routes of administration may help to alleviate some of this burden and improve adherence to prophylaxis therapy.
This symposium, entitled ‘Taking FVIII into the
...
Read more »
|
RUGGELL, Liechtenstein -Wednesday, May 30th 2018 [ AETOS Wire ]
(BUSINESS WIRE)-- ORDERFOX.com is proud to announce a new ground-breaking collaboration with industry leader Autodesk; making visualization and procurement even easier. ORDERFOX.com is continuously focused on providing members a more efficient way to conduct daily business. With that always top-of-mind, ORDERFOX.com community members now have an even greater benefit - the integration of the Autodesk Forge platform viewing functionality.
The Viewer now provides community members the ability to view and process potential business opportunities without additional software installed. In addition, as a benefit for existing and new users of Autodesk Fusion 360, Autodesk Inventor and Autodesk AutoCAD software, they will be able to access all of the features of the ORDERFOX.com platform within their chosen software.
The Viewer integration into the global ORDERFOX.com platform brings vast b
...
Read more »
|
With the ICO, Aimedis aims to finance the global roll out of its blockchain- and AI-based eHealth platform, offering investors a unique chance to tap into the revolution of the way patients interact with doctors.
AMSTERDAM & PRAGUE-Saturday, June 2nd 2018 [ AETOS Wire ]
(BUSINESS WIRE)-- Dutch eHealth-provider Aimedis, creator of a blockchain and AI-based platform that allows patients and institutions to safely store and share health information, such as diagnoses, x-rays, blood screens etc., as well as it enables them to perform video consultations, or to get prescriptions for drugs online, now offers AIM, the cryptocurrency to be used for all kinds of services within its platform, to the public.
By offering 300 million tokens with a nominal value of 0,12 US dollars per token, the doctor-led company strives to raise 36 million USD to finance further development of the platform and the international market roll-out, explains CEO Dr. Michael J. Kald
...
Read more »
|
With the ICO, Aimedis aims to finance the global roll out of its blockchain- and AI-based eHealth platform, offering investors a unique chance to tap into the revolution of the way patients interact with doctors.
AMSTERDAM & PRAGUE-Saturday, June 2nd 2018 [ AETOS Wire ]
(BUSINESS WIRE)-- Dutch eHealth-provider Aimedis, creator of a blockchain and AI-based platform that allows patients and institutions to safely store and share health information, such as diagnoses, x-rays, blood screens etc., as well as it enables them to perform video consultations, or to get prescriptions for drugs online, now offers AIM, the cryptocurrency to be used for all kinds of services within its platform, to the public.
By offering 300 million tokens with a nominal value of 0,12 US dollars per token, the doctor-led company strives to raise 36 million USD to finance further development of the platform and the international market roll-out, explains CEO Dr. Michael J. Kald
...
Read more »
|
REYKJAVÍK, Iceland-Tuesday, May 29th 2018 [ AETOS Wire ]
(BUSINESS WIRE) -- Svandis and Cindicator have entered into a strategic partnership as part of the Cindicator Symbiotic Network. At the core of the partnership, Svandis - a platform for cryptoasset trading and investing analysis - will provide Cindicator with early access to the novel ecosystem of analytics tools and data.
Svandis is led by Hermann Finnbjornsson, CEO and Co-Founder of Svandis, who is a veteran of the tech world, having founded the first cryptocurrency exchange in Iceland, an electronic voting system, and a digital token card for multiple-purpose payments.
The Svandis ecosystem consists of a unified analytical and visualisation platform for analyzing cryptoassets. The data-entry process couples automatic data mining with incentivised data submission from Svandis users. Svandis users receive Svandis tokens (SVN) for data submission and by running a data processing app on their devices.
...
Read more »
| |